@POLR_Investing If you excluce Chops (catalyst) what are down side risk that you see more than up side? October flights is in Line with another strong Quarter.
@DoucheBagInvest@mathlonning Fully agree. If CHOPS wonโt be approved within ER, it will be the third delay. Is not a product equal to competitor? Itโs not a new product. Honestly I donโt understand
@mathlonning In my opinion Chops has been delayed. In august Waleed Keep close short term investor saying late Q3 or beginning Q4. Share Price include Chops not approved now. Foggy days for @Transmedics
@ZackStacksKap Great Zack! Well done! I totally agree your main picture. My concern is regarding short-mid term. CHOPS approval is a ghost, R&D expenses is increasing and company suffering. There is a long road between now and your picture. What do you think about short term?